Fresenius medical care annual general meeting: strong performance against its strategic plan results in highest dividend per share in its history

Shareholders approved the proposed dividend of 1.44 euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history excellent progress in the company's transformation and turnaround plans continues to strengthen the foundation for sustainable, profitable growth in 2024, organic revenue growth1 was 4 percent, and operating income increased by 18 percent on an outlook base2, coming in at the upper end of the company's outlook the company is well positioned for double digit earnings growth in 2025, translating to an 11-12 percent margin bad homburg, germany , may 22, 2025 /prnewswire/ -- fresenius medical care (fme), the world's leading provider of products and services for people with kidney disease, continuously executed its strategic plan during the 2024 fiscal year. the success of this transformation is strengthening the foundation for sustainable, profitable growth — both now and in the future.
GM Ratings Summary
GM Quant Ranking